Skip to content

The influence of maladaptive emotion regulation on inhibition in patients with eating disorders

The influence of maladaptive emotion regulation on inhibition in patients with eating disorders - Emotion regulation and inhibition in eating disorders

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON48862
Enrollment
180
Registered
2019-01-31
Start date
2017-11-14
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

abnormal eating behavior eating disorders

Interventions

emotion regulation
inhibition
eating disorders

Sponsors

Universiteit Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: In order to be eligible to participate in this study, a participant must meet all of the following criteria: All participants are 18 years of age or older and have signed the informed consent. An additional criteria is the diagnosis of either Anorexia Nervosa-Restrictive subtype, Anorexia Nervosa -Binge Purge subtype, Bulimia Nervosa, or Binge Eating Disorder according to the DSM-5. Furthermore, the control group will consist of individuals who are demographically equivalent in age, gender and preferably also education (which is not always feasible) to the patient groups as is determined upon inclusion of several participants in all patient groups.

Exclusion criteria

Exclusion criteria: For all groups, we exclude participants with neurological disorders. Regarding the groups with patients with eating disorders, we exclude patients who are currently suffering from such a severe depression that they do not experience emotions. Moreover, we will exclude patients who are currently under the influence of alcohol or drugs. Regarding the control group, we exclude individuals who have psychiatric or psychological problems as measured with the M.I.N.I. through a telephonic interview.

Design outcomes

Primary

MeasureTime frame
Inhibition measured by performance on Stop Signal Task (SST).

Secondary

MeasureTime frame
Not applicable.

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)